ArticleBMC complementary medicine and therapies2022

Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer.

Shokoofe Noori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.